Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today gave notice that its Annual General Meeting will be held at 10:00am GMT on 26 November 2021 at the offices..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announced its audited results for the year ended 31 May 2021 and provides an update on recent progress and the..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, states that it will be announcing its full year results for the year ended 31 May 2021 on Tuesday, 2 November..
Shares in Oncimmune Holdings with ticker code: LON:ONC has climbed 3.51% or 6.05 points during the course of today’s session so far. Investors seem confident during this period. Range high..
The share price for Northbridge Industrial Services ticker code: LON:NBI has moved up 7.59% or 12 points in today’s trading session so far. Buyers have so far held a positive..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced it has signed an autoantibody profiling agreement with a leading global pharmaceutical company to evaluate the autoantibody profiles of patient samples..
Oncimmune Holdings plc (LON:ONC) drew attention to the pre-publication of new research demonstrating how the use of its EarlyCDT-Lung Test, for diagnosing early stage lung cancer, has been shown to..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the pre-publication of the three-year follow-up data for the Early detection of Cancer of the Lung Scotland trial in..
Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology developed originally at the world-renowned CERN. Over the past two..
Oncimmune Holdings plc (LON:ONC) announced a new contract with the Dana-Farber Cancer Institute (Harvard Medical School affiliate based in Boston, US) whereby the latter will utilise Oncimmune’s proprietary SeroTagTM ‘biomarker..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announces it has signed an autoantibody profiling contract with Dana-Farber Cancer Institute (“Dana-Farber”) in Boston, Massachusetts. Dana-Farber, a clinical affiliate..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today provided a trading update for the 12 months ended 31 May 2021. The Company expects to announce its FY21..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced that it has successfully agreed to acquire the intellectual property and distribution rights for the EarlyCDT® technology in the People’s Republic of China..
The trading price for Norman Broadbent found using EPIC: LON:NBB has increased 10% or 0.56 points during the course of today’s session so far. Buyers have stayed positive during this..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced that it has signed two separate agreements with Roche Pharmaceuticals and Cedars-Sinai Medical Center, in each case to..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announced its interim results for the six months ended 30 November 2020. Commercial highlights Services – ImmunoINSIGHTS · Marked increase in..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, states today that it will be announcing its half year results for the six months ended 30 November 2020 on Monday,..
Stock in Oncimmune Holdings ticker code: LON:ONC has stepped up 3.77% or 6.5 points during the course of today’s session so far. Investors have so far held a positive outlook..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the publication by PLOS ONE of a study, supported by the Oncimmune’s ImmunoINSIGHTS team, which analysed autoantibodies in patients..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced that it has signed a commercial contract to supply its EarlyCDT Lung blood test to NHS Norfolk & Waveney..
